75N95025D00005-75N95026F00001
Delivery Order
Overview
Government Description
Nida center for genetic studies. March 14, 2026 - march 13, 2027. N01DA-23-7787. Task Order 75N95026F00001 (TO4).
Eo 14271: DAP-NCAP-00000089
Awardee
Awarding / Funding Agency
Place of Performance
Piscataway, NJ 8854 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
15
Related Opportunity
(Parent Award)
Infinity Biologix was awarded
Delivery Order 75N95026F00001 (75N950-26-F-00001)
worth up to $2,957,934
by National Institute on Drug Abuse
in March 2026.
The contract
has a duration of 1 year and
was awarded
full & open
with
NAICS 541714 and
PSC AN11
via direct negotiation acquisition procedures.
Status
(Open)
Last Modified 3/11/26
Period of Performance
3/14/26
Start Date
3/13/27
Current End Date
3/13/27
Potential End Date
Obligations
$3.0M
Total Obligated
$3.0M
Current Award
$3.0M
Potential Award
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
75N95025D00005-75N95026F00001
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75N95025D00005-75N95026F00001
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
NPUACRBK7TV9
Awardee CAGE
8MSH6
Agency Detail
Awarding Office
75N950 NATIONAL INSTITUTES OF HEALTH NIDA
Funding Office
75N950
Created By
hhsrbailey1
Last Modified By
hhsjlazarus
Approved By
hhsjlazarus
Legislative
Legislative Mandates
None Applicable
Performance District
NJ-06
Senators
Robert Menendez
Cory Booker
Cory Booker
Representative
Frank Pallone
Modified: 3/11/26